skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Some info to add to yours & others' posts, since it started paying a dividend in ~June 2007 it has grown the dividend at ~20%/annum based on a quarterly basis.

I suspect it will continue growing it.
I have a few shares.

Stan
Read Answer Asked by Stan on June 25, 2015
Q: Hi... what other companies are in the same space as CRH Medical CRH.TO.

Thank you.
Read Answer Asked by Mike on June 25, 2015
Q: Curious if you have any comments on the upcoming Sleep Country Canada IPO. At first glance they seem to have had success with the strategic initiatives they put in place in 2012. Thanks for your insights,
Read Answer Asked by Stephen on June 24, 2015
Q: Please comment on risks , outlook & the size of Market cap --? dividend safety

Thx --Don
Read Answer Asked by Dr. Donald on June 19, 2015
Q: Hi, do you think the stock represent good value here, with the recent pullback in the stock.
Read Answer Asked by samuel on June 17, 2015
Q: Good Afternoon,
I just listened to the conference call from the end of April. Correct me if I'm wrong but I think I heard them say that a realistic longer term goal is now $1Bill in annual revenue? Not sure if I misheard them but they also said their EBITDA margin currently is around 60-65%? And companies like this could trade for 10-13x EBITDA? Thank-you
Read Answer Asked by Chris on June 09, 2015
Q: KLS continues its free fall, time to get out? I'm down 35%, have a long time frame.
Read Answer Asked by Rob on June 09, 2015
Q: After its recent runup, is there much more upside to ATS?
Read Answer Asked by ROB on June 08, 2015
Q: What do you think about CLR? Can you please comment on its relationship with interest rates and how defensive of a stock you think it is?
Thank you.
Read Answer Asked by Arthur on June 08, 2015
Q: Hi,

My question is regarding Andrew Peller's recent results and would like your comments. It looks like a strong quarter with increase in sales, gross margins and a dividend increase.
With a stock having no analyst coverage how does one get a guage on future earnings growth to know when a stock has become "expensive"?
Thanks
Read Answer Asked by David on June 08, 2015
Q: Please give your opinion on the GUD announcement today.
Read Answer Asked by mike on June 08, 2015
Q: Hi Peter,

Could you pls give me your views on the latest quarterly results of input capital and what are the prospects for this streaming company going forward.


Thanks
Paul

Thanks
Read Answer Asked by PAUL on June 05, 2015
Q: GDI Integrated Facility Services:
Can you have a look to this company and give me your opinion on it. I understand that the market cap is a bit small for now.
Read Answer Asked by Olivier on June 03, 2015
Q: Hello Peter & Co,
I'm hanging on to FSV for a while longer until I decide what to do (keep FSV, keep CIG, keep both, sell both. A cursory comparison between the 2 divisions indicate that Colliers was more profitable in 2014 with EBITDA to Revenue ratio of 9.8% vs 7.5% for FSV; a hardly sufficient basis of comparison.
What intrigues me is your rational for shedding the old FSV a couple of months ago.
You're suggesting to hang on for a while longer; but how will one decide what to do next?
Thanks,
Antoine
Read Answer Asked by Antoine on June 03, 2015
Q: Hey Peter & Team,

To date I have done very well on EFN and yesterday as a prudent measure not ever wanting to be the pig that gets slaughtered took some profit off the table.

Today I noticed the recent financing via Element Financial Corp Sub Receipts (EFN/N) is up almost 9% from $17 - $18.50 on 2.02 million volume while EFN is down 1.22% to $18.57.

Can you help me better understand the relationship between these two issues and what EFN/N increasing from $17 - $18.50 means for us little people.

Thanks for all you do

Gord
Read Answer Asked by Gord on June 01, 2015